Copyright Reports & Markets. All rights reserved.

Global Guaifenesin Market Insights and Forecast to 2026

Buy now

1 Study Coverage

  • 1.1 Guaifenesin Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Guaifenesin Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Guaifenesin Market Size Growth Rate by Type
    • 1.4.2 98%-99%
    • 1.4.3 Above 99%
  • 1.5 Market by Application
    • 1.5.1 Global Guaifenesin Market Size Growth Rate by Application
    • 1.5.2 Pharmaceuticals
    • 1.5.3 Personal Care Products
    • 1.5.4 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Guaifenesin Market Size, Estimates and Forecasts
    • 2.1.1 Global Guaifenesin Revenue 2015-2026
    • 2.1.2 Global Guaifenesin Sales 2015-2026
  • 2.2 Global Guaifenesin, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Guaifenesin Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Guaifenesin Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Guaifenesin Competitor Landscape by Players

  • 3.1 Guaifenesin Sales by Manufacturers
    • 3.1.1 Guaifenesin Sales by Manufacturers (2015-2020)
    • 3.1.2 Guaifenesin Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Guaifenesin Revenue by Manufacturers
    • 3.2.1 Guaifenesin Revenue by Manufacturers (2015-2020)
    • 3.2.2 Guaifenesin Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Guaifenesin Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Guaifenesin Revenue in 2019
    • 3.2.5 Global Guaifenesin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Guaifenesin Price by Manufacturers
  • 3.4 Guaifenesin Manufacturing Base Distribution, Product Types
    • 3.4.1 Guaifenesin Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Guaifenesin Product Type
    • 3.4.3 Date of International Manufacturers Enter into Guaifenesin Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Guaifenesin Market Size by Type (2015-2020)
    • 4.1.1 Global Guaifenesin Sales by Type (2015-2020)
    • 4.1.2 Global Guaifenesin Revenue by Type (2015-2020)
    • 4.1.3 Guaifenesin Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Guaifenesin Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Guaifenesin Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Guaifenesin Revenue Forecast by Type (2021-2026)
    • 4.2.3 Guaifenesin Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Guaifenesin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Guaifenesin Market Size by Application (2015-2020)
    • 5.1.1 Global Guaifenesin Sales by Application (2015-2020)
    • 5.1.2 Global Guaifenesin Revenue by Application (2015-2020)
    • 5.1.3 Guaifenesin Price by Application (2015-2020)
  • 5.2 Guaifenesin Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Guaifenesin Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Guaifenesin Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Guaifenesin Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Guaifenesin by Country
    • 6.1.1 North America Guaifenesin Sales by Country
    • 6.1.2 North America Guaifenesin Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Guaifenesin Market Facts & Figures by Type
  • 6.3 North America Guaifenesin Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Guaifenesin by Country
    • 7.1.1 Europe Guaifenesin Sales by Country
    • 7.1.2 Europe Guaifenesin Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Guaifenesin Market Facts & Figures by Type
  • 7.3 Europe Guaifenesin Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Guaifenesin by Region
    • 8.1.1 Asia Pacific Guaifenesin Sales by Region
    • 8.1.2 Asia Pacific Guaifenesin Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Guaifenesin Market Facts & Figures by Type
  • 8.3 Asia Pacific Guaifenesin Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Guaifenesin by Country
    • 9.1.1 Latin America Guaifenesin Sales by Country
    • 9.1.2 Latin America Guaifenesin Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Guaifenesin Market Facts & Figures by Type
  • 9.3 Central & South America Guaifenesin Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Guaifenesin by Country
    • 10.1.1 Middle East and Africa Guaifenesin Sales by Country
    • 10.1.2 Middle East and Africa Guaifenesin Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Guaifenesin Market Facts & Figures by Type
  • 10.3 Middle East and Africa Guaifenesin Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Granules
    • 11.1.1 Granules Corporation Information
    • 11.1.2 Granules Description and Business Overview
    • 11.1.3 Granules Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Granules Guaifenesin Products Offered
    • 11.1.5 Granules Related Developments
  • 11.2 Synthokem Labs
    • 11.2.1 Synthokem Labs Corporation Information
    • 11.2.2 Synthokem Labs Description and Business Overview
    • 11.2.3 Synthokem Labs Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Synthokem Labs Guaifenesin Products Offered
    • 11.2.5 Synthokem Labs Related Developments
  • 11.3 Haizhou Pharma
    • 11.3.1 Haizhou Pharma Corporation Information
    • 11.3.2 Haizhou Pharma Description and Business Overview
    • 11.3.3 Haizhou Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Haizhou Pharma Guaifenesin Products Offered
    • 11.3.5 Haizhou Pharma Related Developments
  • 11.4 Yuan Cheng Group
    • 11.4.1 Yuan Cheng Group Corporation Information
    • 11.4.2 Yuan Cheng Group Description and Business Overview
    • 11.4.3 Yuan Cheng Group Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Yuan Cheng Group Guaifenesin Products Offered
    • 11.4.5 Yuan Cheng Group Related Developments
  • 11.5 Stellar Chemical
    • 11.5.1 Stellar Chemical Corporation Information
    • 11.5.2 Stellar Chemical Description and Business Overview
    • 11.5.3 Stellar Chemical Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Stellar Chemical Guaifenesin Products Offered
    • 11.5.5 Stellar Chemical Related Developments
  • 11.6 Biesterfeld
    • 11.6.1 Biesterfeld Corporation Information
    • 11.6.2 Biesterfeld Description and Business Overview
    • 11.6.3 Biesterfeld Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Biesterfeld Guaifenesin Products Offered
    • 11.6.5 Biesterfeld Related Developments
  • 11.7 Seven Star Pharma
    • 11.7.1 Seven Star Pharma Corporation Information
    • 11.7.2 Seven Star Pharma Description and Business Overview
    • 11.7.3 Seven Star Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Seven Star Pharma Guaifenesin Products Offered
    • 11.7.5 Seven Star Pharma Related Developments
  • 11.8 Camlin Fine Science
    • 11.8.1 Camlin Fine Science Corporation Information
    • 11.8.2 Camlin Fine Science Description and Business Overview
    • 11.8.3 Camlin Fine Science Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Camlin Fine Science Guaifenesin Products Offered
    • 11.8.5 Camlin Fine Science Related Developments
  • 11.9 Gennex Lab
    • 11.9.1 Gennex Lab Corporation Information
    • 11.9.2 Gennex Lab Description and Business Overview
    • 11.9.3 Gennex Lab Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Gennex Lab Guaifenesin Products Offered
    • 11.9.5 Gennex Lab Related Developments
  • 11.10 Iwaki Seiyaku
    • 11.10.1 Iwaki Seiyaku Corporation Information
    • 11.10.2 Iwaki Seiyaku Description and Business Overview
    • 11.10.3 Iwaki Seiyaku Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Iwaki Seiyaku Guaifenesin Products Offered
    • 11.10.5 Iwaki Seiyaku Related Developments
  • 11.1 Granules
    • 11.1.1 Granules Corporation Information
    • 11.1.2 Granules Description and Business Overview
    • 11.1.3 Granules Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Granules Guaifenesin Products Offered
    • 11.1.5 Granules Related Developments
  • 11.12 Delta Synthetic
    • 11.12.1 Delta Synthetic Corporation Information
    • 11.12.2 Delta Synthetic Description and Business Overview
    • 11.12.3 Delta Synthetic Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Delta Synthetic Products Offered
    • 11.12.5 Delta Synthetic Related Developments
  • 11.13 Smart Pharm
    • 11.13.1 Smart Pharm Corporation Information
    • 11.13.2 Smart Pharm Description and Business Overview
    • 11.13.3 Smart Pharm Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Smart Pharm Products Offered
    • 11.13.5 Smart Pharm Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Guaifenesin Market Estimates and Projections by Region
    • 12.1.1 Global Guaifenesin Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Guaifenesin Revenue Forecast by Regions 2021-2026
  • 12.2 North America Guaifenesin Market Size Forecast (2021-2026)
    • 12.2.1 North America: Guaifenesin Sales Forecast (2021-2026)
    • 12.2.2 North America: Guaifenesin Revenue Forecast (2021-2026)
    • 12.2.3 North America: Guaifenesin Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Guaifenesin Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Guaifenesin Sales Forecast (2021-2026)
    • 12.3.2 Europe: Guaifenesin Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Guaifenesin Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Guaifenesin Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Guaifenesin Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Guaifenesin Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Guaifenesin Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Guaifenesin Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Guaifenesin Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Guaifenesin Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Guaifenesin Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Guaifenesin Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Guaifenesin Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Guaifenesin Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Guaifenesin Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Guaifenesin Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Guaifenesin Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Guaifenesin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Guaifenesin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Guaifenesin market is segmented into
    98%-99%
    Above 99%

    Segment by Application, the Guaifenesin market is segmented into
    Pharmaceuticals
    Personal Care Products
    Others

    Regional and Country-level Analysis
    The Guaifenesin market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Guaifenesin market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Guaifenesin Market Share Analysis
    Guaifenesin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Guaifenesin business, the date to enter into the Guaifenesin market, Guaifenesin product introduction, recent developments, etc.

    The major vendors covered:
    Granules
    Synthokem Labs
    Haizhou Pharma
    Yuan Cheng Group
    Stellar Chemical
    Biesterfeld
    Seven Star Pharma
    Camlin Fine Science
    Gennex Lab
    Iwaki Seiyaku
    Pan Drugs
    Delta Synthetic
    Smart Pharm

    Buy now